Insider Trading: AcelRx Pharmaceuticals Inc (ACRX.O)
ACRX.O on Consolidated Issue listed on NASDAQ Global Market
9.60USD
18 Jun 2013
9.60USD
18 Jun 2013
Price Change (% chg)
$-0.32 (-3.23%)
$-0.32 (-3.23%)
Prev Close
$9.92
$9.92
Open
$10.00
$10.00
Day's High
$10.13
$10.13
Day's Low
$9.40
$9.40
Volume
353,339
353,339
Avg. Vol
433,029
433,029
52-wk High
$10.59
$10.59
52-wk Low
$2.27
$2.27
| WAN MARK A | Options Exercised: 0 | ||
| Trade Date: | Monday, 28 May 2012 | Price: | 3.40 |
| Title: | Director and Beneficial Owner | Shares Held: | 7,950,123 |
| Type Traded: | Indirect | Net Change in Shares This Filing: | 284,698 |
Institutional Holders
| % Shares Owned: | 80.48% |
| # of Holders: | 46 |
| Total Shares Held: | 29,969,592 |
| 3 Mo. Net Change: | -1,259,195 |
| # New Positions: | 13 |
| # Closed Positions: | 9 |
| # Increased Positions: | 25 |
| # Reduced Positions: | 16 |
| # Net Buyers: | 9 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Adrian Adams |
62 | 2013 | Independent Chairman of the Board |
Richard King |
48 | 2010 | President, Chief Executive Officer, Director |
James Welch |
55 | 2010 | Chief Financial Officer |
Pamela Palmer |
50 | 2005 | Chief Medical Officer, Director |
Badri Dasu |
49 | 2007 | Chief Engineering Officer |
Lawrence Hamel |
61 | 2006 | Chief Development Officer |
Mark Edwards |
55 | 2011 | Independent Director |
Stephen Hoffman |
58 | 2010 | Independent Director |
Guy Nohra |
52 | 2006 | Independent Director |
Howard Rosen |
54 | 2008 | Independent Director |
Mark Wan |
47 | 2006 | Independent Director |

